Find Program

Course Details

MPOX AND VACCINATION

  • Home
  • MPOX AND VACCINATION
girl
Total Duration: 34 hrs
Synchronous Online Training: 10 hrs
Face To Face Training: 8 hrs
Self-Paced Learning: 10 Hours
Pre/post Test: (1hr Each)
Written Assignment: 4hrs
Support and Assistance: 24/7
Student: 30 Students
Join Course
AKGLS learning

MPOX AND VACCINATION

( 5.0 )
Overview

The Mpox and Vaccination Training Program aims to equip healthcare professionals with comprehensive knowledge and practical skills for the clinical management and prevention of Mpox. Through a series of focused modules, participants will gain expertise in identifying, assessing, and treating various stages of Mpox, understanding vaccination principles, and implementing infection prevention measures. The program also covers antiviral therapies, care for high-risk populations, and immunization techniques to enhance the quality of care and promote public health resilience against Mpox outbreaks.

ICT Requirements

  • Computer/ Laptop with Microphone & Camera in working condition
  • Good Internet
  • Access to Google Forms / MS Forms
  • Ability to perform basic MS word and Excel
Learning Outcomes

By the end of the training, participants will be able to.

1. Identify and differentiate MPox from other viral infections, understanding its clinical manifestations and progression.
2. Implement effective screening, triage, and isolation protocols to prevent transmission and ensure timely management of suspected MPox cases.
3. Apply evidence-based strategies for managing mild or uncomplicated MPox cases in outpatient settings, as well as specialized care for high-risk patients and those with complicated cases.
4. Utilize infection prevention and control (IPC) measures within healthcare facilities to safeguard healthcare workers and patients from MPox exposure.
5. Apply the appropriate use of antiviral therapies and immune globulin in the treatment of MPox, tailoring approaches to individual patient needs.
6. Recognize the unique considerations for specific populations affected by MPox, including pregnant women, postpartum individuals, and young children, and provide tailored care accordingly.
7. Explain the fundamental principles of vaccinology, including the types of MPox vaccines available and their efficacy, to promote informed immunization practices.
8. Execute proper immunization techniques and best practices for vaccine administration, ensuring patient safety and effective delivery of MPox vaccinations.
Assessment

Throughout the Comprehensive MPox Prevention and Clinical Management training, various assessment techniques will be employed to evaluate participants' understanding and proficiency in managing MPox effectively. These techniques include:

Pre-Test: Before the training begins, participants will complete a pre-test to assess their baseline knowledge of MPox concepts and clinical management strategies. This initial assessment will help tailor the course content to address specific learning needs and gaps.

Progress Assessment Online Tests: Participants will engage in daily online tests designed to reinforce learning and assess comprehension of the material covered each day. These tests will consist of multiple-choice questions, quizzes, or short-answer exercises aimed at evaluating understanding of daily topics and concepts related to MPox.

Post-Test: At the conclusion of the training, participants will complete a comprehensive post-test covering all modules and topics discussed during the training period. This final assessment will provide a thorough evaluation of participants' knowledge and skills in the prevention and clinical management of MPox.

Case Study Questions: Participants will be presented with case study questions simulating real-world scenarios related to MPox management. These case studies will challenge participants to apply their knowledge to practical situations, analyze clinical data, and develop appropriate management plans.

Self-Paced Learning Tests on the LMS: : The Learning Management System (LMS) will host self-paced learning tests that participants can access at their convenience. These tests will allow participants to review course material, reinforce key concepts, and assess their understanding through interactive quizzes and exercises.

Passing Criteria

To qualify for a certificate of participation, candidates must achieve a minimum passing score of 80% or above on the post-test administered at the end of the training. This threshold ensures participants have demonstrated a high level of comprehension and competency in MPox prevention and clinical management principles and practices.

Target Audience

This training is designed for healthcare professionals and individuals involved in the management and care of patients with MPox, including clinicians, nurses, public health workers, and mental health professionals.

Training Modality
  • Total Duration: Participants are expected to commit a total of 34 hours to complete the training.
  • Blended Learning Approach:
    • Synchronous (Live Online Training): 10 hours of live, interactive sessions conducted online (3-hour sessions over 3 consecutive days).
    • Face-to-Face Training: 8 hours of in-person learning, which includes:
      • 4 hours of interactive lectures and discussions.
      • 4 hours of hands-on practice focused on Infection Prevention and Control (IPC) and vaccination techniques.
  • Pre/Post-Training Assessment: 2 hours allocated for pre- and post-test evaluations to assess learning outcomes.
  • Self-Paced Learning: 10 hours of self-directed study, allowing participants to engage with course materials at their own pace.
  • Written Assignment: 4 hours dedicated to completing a written assignment, consolidating key learning points from the training.
How to Obtain Credit

To obtain CPD or CME Credit, complete the post-tests with an 80% pass rate. Complete the evaluation survey on-line and submit. A certificate will be mailed within a week of course completion date to the E-mail address provided at the time of registration.

Curriculum

This module provides an in-depth understanding of the clinical features of MPox, focusing on the virus's natural history, severity, and progression. Participants will explore the key signs and symptoms that differentiate MPox from other viral infections, the transmission routes, and the dynamics of viral shedding. Special attention will be given to vulnerable populations, such as pregnant women and postpartum individuals, along with discussions on the mid- and long-term effects of the infection. By the end of the module, participants will have a clear understanding of how to clinically characterize MPox cases for timely diagnosis and appropriate intervention.

Learning Objectives

By the end of this module, participants will be able to:

1. Describe the stages and progression of MPox infection, including factors that influence the severity of the disease.
2. Recognize and differentiate the clinical manifestations of MPox from other similar viral infections.
3. Utilize clinical knowledge to distinguish MPox from chickenpox, herpes, and other exanthematous diseases.
4. Analyze how MPox is transmitted between individuals and understand the patterns of viral shedding that affect the risk of contagion.
5. Apply specific clinical considerations for managing MPox in pregnant women and postpartum individuals.
6. Evaluate the potential chronic symptoms and complications that may arise after acute MPox infection.

This module focuses on the critical processes of screening, triage, isolation, and clinical assessment in the context of MPox. Participants will learn how to identify suspected cases of MPox in both clinical and community settings through structured screening and triage protocols. The module also provides practical guidelines on effective isolation techniques to prevent transmission of the virus. Additionally, participants will be trained in clinical assessment methods to evaluate and categorize the severity of MPox, ensuring prompt and appropriate management of patients based on their condition.

Learning Objectives

By the end of this module, participants will be able to:

1. Identify suspected MPox cases in a timely manner using established screening and triage guidelines, both in clinical and community environments.
2. Understand and implement isolation procedures to prevent the spread of MPox, ensuring the safety of both healthcare workers and the community.
3. Perform initial clinical evaluations of MPox patients to determine the severity of the disease and guide appropriate interventions.
4. Distinguish between mild, moderate, and severe cases of MPox, and assign the necessary level of care based on the patient’s condition.
5. Tailor screening, triage, and isolation protocols to the unique challenges posed by different healthcare and community settings, from hospitals to rural areas.

This module provides essential guidance on managing mild or uncomplicated MPox cases, particularly in outpatient or community settings. Participants will explore best practices for delivering care to patients outside of hospital environments, with a focus on infection prevention and control (IPC) to minimize community transmission. The module covers clinical considerations such as pain management, nutritional support, and regular monitoring of patients for potential complications. Special attention is given to the management of MPox-related skin lesions, offering practical strategies to support recovery while preventing secondary infections.

Learning Objectives

By the end of this module, participants will be able to:

1. Deliver effective care to MPox patients in outpatient or community environments, reducing the need for hospitalization while ensuring patient safety and recovery.
2. Apply IPC strategies to minimize transmission risks in community settings, including the patient’s home.
3. Identify appropriate treatments for managing pain in MPox patients, ensuring patient comfort throughout their recovery.
4. Understand the nutritional needs of MPox patients and provide guidance on dietary support to aid in their recovery.
5. Regularly assess vital signs and other clinical markers to identify and address complications early in mild MPox cases.
6. Apply clinical techniques for treating MPox-related skin lesions, including wound care strategies to promote healing and prevent secondary infections.

This module provides comprehensive training on infection prevention and control (IPC) strategies specifically for health facilities managing confirmed MPox cases. Participants will learn about critical IPC considerations, including the proper use of personal protective equipment (PPE), disinfection protocols, and safeguarding healthcare workers. The module also covers essential practices for environmental cleaning and waste disposal to ensure the containment of MPox within healthcare settings, thereby protecting both staff and other patients from contamination.

Learning Objectives

By the end of this module, participants will be able to:

    1. Implement effective IPC measures for managing confirmed MPox cases, including the correct use of PPE and adherence to disinfection protocols.
    2. Understand and apply strategies to safeguard healthcare workers from MPox exposure while treating patients, ensuring their safety and minimizing transmission risks.
    3. Identify and implement appropriate environmental cleaning procedures to prevent contamination within healthcare facilities.
    4. Apply protocols for the safe disposal of waste generated from the care of MPox patients, ensuring compliance with public health standards and minimizing the risk of virus spread.
    5. Oversee the enforcement of IPC protocols across all levels of healthcare facility operations, reducing the likelihood of facility-based transmission.

This module focuses on the treatment options available for MPox, emphasizing the role of antiviral therapies and immune globulin in managing the infection. Participants will gain insights into specific antivirals used for MPox, including Tecovirimat, Brincidofovir, and Cidofovir, exploring their mechanisms of action, appropriate dosages, and efficacy in treating both mild and severe cases. Additionally, the module will discuss emerging antiviral therapies such as NIOCH-14 and the role of immune globulin in supporting the treatment of MPox patients.

Learning Objectives

By the end of this module, participants will be able to:

    1. Describe how Tecovirimat works, including its dosage guidelines and proven efficacy in treating MPox.
    2. Identify scenarios in which Brincidofovir and Cidofovir are appropriate for use in severe or complicated MPox cases.
    3. Discuss the potential of NIOCH-14 and other emerging antiviral treatments for MPox, considering their mechanisms and preliminary findings.
    4. Explain how immune globulin can be utilized in the management of MPox, including its benefits and limitations in treatment.
    5. Integrate knowledge of antiviral therapies and immune globulin into comprehensive treatment plans for MPox patients based on severity and individual circumstances.

This module addresses the specialized management required for high-risk patients and those experiencing complicated or severe cases of MPox. Participants will learn about the protocols tailored for immunocompromised individuals and the elderly, emphasizing the unique challenges these populations face. The module will also cover the necessary follow-up care and monitoring for patients recovering from acute MPox infection, as well as guidelines for managing deceased patients to prevent further transmission. Additionally, participants will explore post-exposure protocols for healthcare workers who may have been at risk of contracting MPox.

Learning Objectives

By the end of this module, participants will be able to:

    1. Identify and apply special management strategies for immunocompromised and elderly patients with MPox to mitigate risks and improve outcomes.
    2. Develop follow-up care plans for MPox patients post-acute infection, including monitoring for long-term symptoms and potential complications.
    3. Understand and implement protocols for the respectful and safe handling of deceased individuals with confirmed MPox to prevent further transmission of the virus.
    4. Establish appropriate post-exposure management plans for healthcare workers who may have been exposed to MPox, including monitoring and preventive measures.
    5. Work effectively within multidisciplinary teams to ensure comprehensive care for high-risk patients, including coordination with specialists and support services.

This module focuses on the unique challenges and considerations for specific populations affected by MPox, including sexually active individuals, pregnant and postpartum women, and young children. Participants will learn about the transmission dynamics of MPox through sexual contact and the importance of providing tailored care for these populations. The module also addresses the clinical management of MPox in pregnant and postpartum women, highlighting the specific needs of these patients. Additionally, participants will explore strategies for caring for infants and young children with MPox, as well as breastfeeding recommendations for mothers infected with the virus.

Learning Objectives

By the end of this module, participants will be able to:

    1. Recognize and manage the transmission risks of MPox among sexually active individuals, implementing appropriate prevention and care strategies.
    2. Identify special considerations and clinical management strategies for women during and after pregnancy who are diagnosed with MPox, ensuring maternal and fetal safety.
    3. Apply specific clinical management strategies for infants and young children diagnosed with MPox, understanding the unique challenges they face.
    4. Understand the precautions and recommendations for breastfeeding in mothers infected with MPox, ensuring the health and safety of both mother and child.
    5. Work effectively with multidisciplinary teams, including pediatricians and obstetricians, to provide comprehensive care tailored to the needs of vulnerable populations.

This module provides a foundational understanding of vaccinology and the principles of immunization, with a focus on their application in the prevention of viral diseases, particularly Mpox. Participants will explore basic immunological concepts, including how the immune system responds to pathogens and vaccines. The module also covers the different types of vaccines (live attenuated, inactivated, subunit, mRNA, etc.), their mechanisms of action, and their role in public health. Special emphasis is placed on understanding how vaccines contribute to controlling outbreaks and preventing the spread of diseases like Mpox.

Learning Objectives

By the end of this module, participants will be able to:

    1. Understand the basic immunological concepts underlying vaccine-induced immunity. 2. Identify the various types of vaccines and explain their mechanisms of action. 3. Comprehend the principles of immunization and its role in disease prevention, particularly for viral infections like Mpox. 4. Discuss the significance of vaccines in controlling infectious diseases and preventing outbreaks. 5. Apply knowledge of vaccine science to evaluate and advocate for immunization strategies in public health settings.

This module provides an in-depth exploration of the vaccines available for Mpox, focusing on their mechanisms of action, efficacy, and clinical data from recent trials. Participants will learn about the different types of Mpox vaccines, including their development and approval processes. The module will also cover the effectiveness of these vaccines in preventing Mpox infection, as well as their limitations in certain populations. By the end of the session, participants will be equipped with the knowledge needed to evaluate vaccine options for Mpox prevention and make informed decisions in clinical practice.

Learning Objectives

By the end of this module, participants will be able to:

    1. Identify the different types of vaccines available for Mpox and describe their mechanisms of action.
    2. Analyze the efficacy data of Mpox vaccines, including outcomes from clinical trials and real-world studies.
    3. Understand the criteria used to evaluate vaccine effectiveness and safety.
    4. Discuss the benefits and limitations of Mpox vaccines, particularly in high-risk or vulnerable populations.
    5. Apply knowledge of Mpox vaccines to recommend appropriate immunization strategies in clinical settings.

This module offers practical guidance on the proper techniques for administering Mpox vaccines, focusing on best practices for vaccine handling, storage, and safety. Participants will learn how to ensure the efficacy of vaccines through proper administration techniques and adherence to safety protocols. Additionally, the module covers contraindications and precautions, along with strategies to manage side effects that may occur post-vaccination. By the end of this module, participants will be prepared to confidently administer Mpox vaccines while maintaining high safety standards.

Learning Objectives

By the end of this module, participants will be able to:

    1. Demonstrate proper vaccine administration techniques for Mpox, ensuring safety and efficacy.
    2. Understand and apply best practices for vaccine handling, storage, and transportation to preserve vaccine potency.
    3. Identify contraindications and precautions for Mpox vaccination, recognizing populations at higher risk of complications.
    4. Manage common side effects and adverse reactions following Mpox vaccination, including appropriate post-vaccination care.
    5. Implement safety protocols to minimize errors in vaccine administration and improve patient outcomes.
When would you like to start?

Start straight away and join a global classroom of learners. If the course hasn’t started, yet you’ll see the future date listed below.

Join Today Available now